154 related articles for article (PubMed ID: 1514138)
1. [Plasma cell leukemia. Study of 6 patients].
Las Heras G; Ribera JM; Abella E; Batlle M; Flores A; Millá F; Feliu E
Sangre (Barc); 1992 Aug; 37(4):255-8. PubMed ID: 1514138
[TBL] [Abstract][Full Text] [Related]
2. [Plasma cell leukemia. Study of 10 cases].
López Guillermo A; Martí JM; Bladé J; Nomdedeu B; Montserrat E; Rozman C
Sangre (Barc); 1989 Feb; 34(1):28-31. PubMed ID: 2652343
[TBL] [Abstract][Full Text] [Related]
3. Plasma cell leukemia: a rare condition.
Jiménez-Zepeda VH; Domínguez VJ
Ann Hematol; 2006 Apr; 85(4):263-7. PubMed ID: 16416115
[TBL] [Abstract][Full Text] [Related]
4. [Plasma cell leukemia: our experience in 4 cases].
Manso F; Bello JL; Feliu J; García de Bustos J; Losada G; Quevedo E
Rev Clin Esp; 1991 Nov; 189(7):328-30. PubMed ID: 1767090
[TBL] [Abstract][Full Text] [Related]
5. Plasma cell leukemia. A report on 11 patients and review of the literature.
Pasqualetti P; Festuccia V; Collacciani A; Acitelli P; Casale R
Panminerva Med; 1996 Sep; 38(3):179-84. PubMed ID: 9009684
[TBL] [Abstract][Full Text] [Related]
6. Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.
Vela-Ojeda J; García-Ruiz Esparza MA; Rosas-Cabral A; Padilla-González Y; García-Chávez J; Tripp-Villanueva F; Sánchez-Cortés E; Ayala-Sánchez M; García-León LD; Montiel-Cervantes L; Rubio-Borja ME
Ann Hematol; 2002 Jul; 81(7):362-7. PubMed ID: 12185504
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and evolutive study of plasma cell leukemia. Apropos of 9 cases].
Panizo Santos C; Cuesta Palomero B; Calasanz Abinzano MJ; Rifón Roca J; Rocha Hernando E
Rev Clin Esp; 1997 May; 197(5):341-5. PubMed ID: 9280968
[TBL] [Abstract][Full Text] [Related]
8. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
[TBL] [Abstract][Full Text] [Related]
9. Primary plasma cell leukemia occuring in the young.
Raj RS; Najeeb S; Aruna R; Pavithran K; Thomas M
Indian J Cancer; 2003; 40(3):116-7. PubMed ID: 14716116
[TBL] [Abstract][Full Text] [Related]
10. [Plasma cell leukemia].
Egli F; Rhyner K
Schweiz Rundsch Med Prax; 1989 Jan; 78(3):29-34. PubMed ID: 2919252
[TBL] [Abstract][Full Text] [Related]
11. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression.
Mateos MV; Hernández JM; Hernández MT; Gutiérrez NC; Palomera L; Fuertes M; Garcia-Sanchez P; Lahuerta JJ; de la Rubia J; Terol MJ; Sureda A; Bargay J; Ribas P; Alegre A; de Arriba F; Oriol A; Carrera D; García-Laraña J; García-Sanz R; Bladé J; Prósper F; Mateo G; Esseltine DL; van de Velde H; San Miguel JF
Haematologica; 2008 Apr; 93(4):560-5. PubMed ID: 18322252
[TBL] [Abstract][Full Text] [Related]
12. Significantly better prognosis for patients with primary plasma cell leukemia than for patients with secondary plasma cell leukemia.
Cha CH; Park CJ; Huh JR; Chi HS; Suh CW; Kang YK
Acta Haematol; 2007; 118(3):178-82. PubMed ID: 17934254
[TBL] [Abstract][Full Text] [Related]
13. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
[TBL] [Abstract][Full Text] [Related]
14. A retrospective analysis of thirty-one cases of plasma cell leukemia from a single center in China.
Peijing Q; Yan X; Yafei W; Dehui Z; Zengjun L; Junyuan Q; Yaozhong Z; Lugui Q
Acta Haematol; 2009; 121(1):47-51. PubMed ID: 19339770
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of bortezomib in patients with plasma cell leukemia.
Musto P; Rossini F; Gay F; Pitini V; Guglielmelli T; D'Arena G; Ferrara F; Filardi N; Guariglia R; Palumbo A; ; ;
Cancer; 2007 Jun; 109(11):2285-90. PubMed ID: 17469169
[TBL] [Abstract][Full Text] [Related]
16. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH
Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039
[TBL] [Abstract][Full Text] [Related]
17. Primary systemic amyloidosis with delayed progression to multiple myeloma.
Rajkumar SV; Gertz MA; Kyle RA
Cancer; 1998 Apr; 82(8):1501-5. PubMed ID: 9554527
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
Dingli D; Rajkumar SV; Nowakowski GS; Gertz MA; Dispenzieri A; Lacy MQ; Hayman S; Fonseca R; Lust JA; Kyle RA; Greipp PR; Witzig TE
Haematologica; 2005 Dec; 90(12):1650-4. PubMed ID: 16330438
[TBL] [Abstract][Full Text] [Related]
19. Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.
Alegre A; Granda A; Martínez-Chamorro C; Díaz-Mediavilla J; Martínez R; García-Laraña J; Lahuerta JJ; Sureda A; Bladé J; de la Rubia J; Fernández-Rañada JM; San Miguel J; ; ;
Haematologica; 2002 Jun; 87(6):609-14. PubMed ID: 12031917
[TBL] [Abstract][Full Text] [Related]
20. [IgG-lambda-type multiple myeloma with plasma-cell pericardial effusion and terminal plasma-cell leukemia].
Klug S; Höltermann F; Fritsch H
Dtsch Med Wochenschr; 1992 Jun; 117(23):900-4. PubMed ID: 1597118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]